Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone in Tourette Syndrome
NCT00004393Phase 2Completed
- Sponsor
- National Center for Research Resources
- Start
- Jul 1997
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of risperidone in Tourette syndrome (TS), sponsored by National Center for Research Resources. Started Jul 1997; status: completed.
02
Drugs
risperidone
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on NCT00004393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004393.